Sinumed

Quick links to important sections

Sinumed

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sinumed

Property Description
Active Ingredient Pseudoephedrine Hydrochloride (C10H16ClNO)
Form Tablet, Capsule (Immediate-release and extended-release)
Pharmacological Class Sympathomimetic Amine, Systemic Decongestant
General Purpose Relief of upper respiratory and nasal congestion
Origin Synthetic

What Type of Medicine is Sinumed?

Sinumed is a specific pharmaceutical preparation classified as a systemic decongestant, formulated for oral administration to target congestion in the nasal and sinus passages. The core active compound is Pseudoephedrine Hydrochloride (Pseudoephedrine Hcl), which places the drug within the sympathomimetic amine pharmacological class. This compound is of synthetic origin and functions as an α-adrenergic agonist, a mechanism that is clinically recognized for its ability to constrict blood vessels. The medicine acts internally through the bloodstream, providing relief that contrasts with localized topical applications.


Composition and General Purpose of Sinumed

The drug is a single-ingredient product, containing Pseudoephedrine Hydrochloride along with necessary inert pharmaceutical excipients that form the solid dosage forms of tablets or capsules. The general purpose of Sinumed is to mitigate the discomfort associated with upper respiratory congestion and sinus pressure, a typical use scenario when a person experiences head fullness. Its core action is to induce vasoconstriction, or the narrowing of blood vessels, in the mucous membranes. This specific physiological action results in the reduction of mucosal edema, confirming that the primary benefit is the physical shrinking of swollen tissues to promote the drainage of blocked airways.

Regulatory References

  1. Pseudoephedrine: MedlinePlus Drug Information

What side effects are possible with Sinumed?

Possible Side Effects and Safety Information

The official safety information for Sinumed (Pseudoephedrine Hydrochloride) details adverse reactions primarily related to its sympathomimetic activity, affecting the central nervous system, heart, and blood vessels. Regulatory documents classify these effects by frequency and system.


Adverse Reaction Frequencies and Systems

Adverse reactions are grouped into categories based on reporting frequency in regulatory documentation:

  • Common Reactions may include nervousness, insomnia, and dry mouth.
  • Uncommon Reactions include anxiety, headache, tremor, tachycardia (fast heart rate), palpitations, nausea, and vomiting.

These effects are typically classified under Psychiatric disorders, Nervous system disorders, Cardiac disorders, and Gastrointestinal disorders.


Serious Adverse Reactions and Safety Restrictions

Regulatory labels document the potential for rare but serious adverse reactions, which include a risk of Hypertensive Crisis (severe increase in blood pressure), stroke, and rare cerebrovascular syndromes such as PRES (Posterior Reversible Encephalopathy Syndrome) and RCVS (Reversible Cerebral Vasoconstriction Syndrome). Severe skin reactions, such as AGEP (Acute Generalized Exanthematous Pustulosis), are also noted.

The regulatory profile specifies strict contraindications (situations where the medicine should not be used). These include patients with severe uncontrolled hypertension, severe coronary artery disease, severe kidney failure, or those taking Monoamine Oxidase Inhibitors (MAOIs), or within 14 days of discontinuing MAOI therapy. Certain stimulating effects, such as nervousness and insomnia, may be more noticeable at the start of treatment.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Sinumed (Pseudoephedrine Hydrochloride) is officially documented in government labeling, defining a profile based on acute sympathomimetic toxicity. Documented clinical manifestations primarily involve the Central Nervous System and Cardiovascular System. These include signs of CNS excitation, such as restlessness, tremor, insomnia, and excitability. Cardiovascular effects commonly listed are hypertension (high blood pressure) and tachycardia (fast or irregular heartbeat).

The official prescribing information cites seizures, cardiac arrhythmias, and hypertensive crisis as potential severe outcomes. Regulator-mandated action requires patients to seek immediate medical attention for any suspected overdose. Emergency services must be contacted immediately if critical symptoms such as collapse, trouble breathing, or a sudden severe headache occur, as these indicate potentially life-threatening events.

Overdose management is restricted to symptomatic and supportive treatment, as regulatory documents state that no specific antidote is known for this compound. Management procedures require close clinical observation, cardiac monitoring, and interventions to control blood pressure. Furthermore, labeling notes an increased susceptibility to severe CNS effects in infants and children.

Therapeutic Uses of Sinumed

Sinumed (Pseudoephedrine Hcl) is generally considered relevant in contexts marked by increased discomfort or tension, applied across domains where additional symptomatic support may be needed for respiratory issues. The medication is commonly used across conditions characterized by periods of heightened symptoms related to swelling in the nasal and sinus passages.

It is commonly used for managing symptom clusters that may become intense or disruptive, including nasal obstruction, sinus congestion, and ear pressure imbalances. Sinumed may be considered relevant for temporary relief during episodes of the common cold, flu, sinusitis, and seasonal allergic rhinitis (hay fever). The relief provided may assist with symptoms that interfere with daily functioning and generally contributes to comfort during periods of heightened congestion. It is often applied during phases of increased distress or discomfort when symptoms become temporarily overwhelming.


Quick Fact: Relief for Congestion and Pressure

Sinumed is commonly used for managing symptoms that interfere with daily functioning and provides symptomatic support in situations involving acute or unstable symptom patterns in the upper respiratory tract.

Regulatory References

  1. NIH MedlinePlus overview of Pseudoephedrine uses

Eligibility and Restrictions for Use

Eligibility for Sinumed (Pseudoephedrine HCl) — Official Regulatory Information

Official regulatory documents define specific populations who can and cannot use Sinumed. Use is generally allowed for adults and children aged 12 years and over. Immediate-release formulations are permitted for children aged 6 to 11 years. The medicine is not recommended for children under 6 years of age, and extended-release formulations are restricted to users 12 years and older.

Population Status Regulatory Eligibility Rule
Absolute Contraindication Patients with severe or uncontrolled hypertension, severe coronary artery disease, severe renal impairment/failure, or those currently taking or recently having taken a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days.
Restricted Use/Caution Caution is mandated for patients with hyperthyroidism, diabetes mellitus, heart disease, glaucoma, or difficulty urinating due to conditions like an enlarged prostate gland.
Not Recommended Status Use is not usually recommended during pregnancy, particularly the first trimester, and while breastfeeding, due to the potential to decrease milk supply.

Regulatory authorities classify use in these groups as strictly prohibited or restricted to ensure appropriate administration across eligible populations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Sinumed contains a sympathomimetic decongestant (pseudoephedrine) and a nonsteroidal anti-inflammatory drug (NSAID, ibuprofen). The interaction profile is determined by these active components.

Highly Significant Interactions (Avoidance Required):

The most critical interaction involves Monoamine Oxidase Inhibitors (MAOIs), which are contraindicated with this product. Combining an MAOI with the pseudoephedrine component can result in a serious, potentially fatal hypertensive crisis due to enhanced pressor effects. This restriction applies even after stopping an MAOI; a washout period of at least 14 days is required before starting Sinumed.

Other Important Interactions:

  • Cardiovascular and Blood Pressure Medicines: Pseudoephedrine can counteract the effects of medicines prescribed for high blood pressure, such as beta-blockers or methyldopa, and may increase blood pressure. Caution is also warranted with drugs like digoxin.
  • Blood Thinners and Anticoagulants: The ibuprofen component increases the risk of bleeding when used with warfarin and other anticoagulants. It may also reduce the cardioprotective effect of low-dose aspirin.
  • Other NSAIDs/Sympathomimetics: Combining Sinumed with other NSAIDs (e.g., naproxen) or other cough-and-cold remedies containing similar decongestants (e.g., pseudoephedrine, phenylephrine) is prohibited to prevent additive side effects and toxicity.
  • Other Medicines: The ibuprofen component may interact with lithium, methotrexate, and steroid medicines (e.g., prednisone), requiring monitoring or dose adjustment by a healthcare professional.

Mechanism of Action

How Sinumed Works — Mechanism of Action

Mechanical Cleansing and Epithelial Fluid Dynamics

This mechanism involves the introduction of a buffered saline solution to the nasal and sinus lining. The action is primarily physical, involving the mechanical washing of the mucosal surface to remove accumulated debris and foreign particulates. The osmotic action of the solution creates a pressure gradient across the epithelium, influencing fluid dynamics and promoting the movement of excess water out of the mucosal tissues. This supports the optimization of natural clearance mechanisms and contributes to increased volume within the nasal passages via fluid reduction, which influences the physical state of the tissues, resulting in altered resistance to airflow.

Mucus Rheology and Ciliary Function Enhancement

The solution modulates the properties of secretions by acting as a solubilizing and hydrating agent. The active components interact with the mucus glycoproteins, decreasing the high viscosity and elasticity that characterize thick secretions. Simultaneously, the solution establishes an optimal moist environment for the cilia to engage in efficient beating. This combined action supports an increase in the rate and efficiency of mucociliary transport, which is essential for shaping the drug's overall physiological effect through the support of robust secretion clearance.

Dosage and Administration Information

Sinumed is designated for oral administration using immediate-release (IR) tablets, extended-release (ER) capsules, or oral solutions. The medication is utilized according to a standardized schedule defined by the formulation type.

For adults and adolescents (12 years and older), the IR dose is typically 30 mg to 60 mg, administered every 4 to 6 hours. The total intake must not exceed the maximum daily dose of 240 mg in a 24-hour period. Extended-release forms, which include 12-hour and 24-hour products, are administered less frequently, typically once or twice daily.

A specific administration requirement for ER formulations is that the tablet or capsule must be swallowed whole and is not to be crushed, broken, or chewed, as this compromises the drug’s intended release profile. The medicine may be taken with or without food. Timing the last dose of the day several hours prior to bedtime may minimize interference with sleep patterns.

Usage is generally intended to be short-term, commonly not exceeding seven days. Specific adjustments are documented for the pediatric population, with lower dose limits and defined regimens for children aged 6 to 11 years. Additionally, caution is exercised when the medicine is administered to older adults and individuals with existing renal impairment.

Recent Clinical Evidence

Sinumed: Recent Clinical Evidence

Sinumed is a fixed-dose combination product containing three active components: acetaminophen (an analgesic and antipyretic), pseudoephedrine (a nasal decongestant), and chlorpheniramine (an antihistamine). The primary evidence for this combination relates to its use for the temporary relief of symptoms associated with upper respiratory tract infections, such as the common cold and sinusitis.


Evidence for Symptom Relief

Clinical trials focusing on the individual components and their combined use suggest a benefit in managing multiple symptoms concurrently. Research has indicated that the pseudoephedrine component may provide a reduction in nasal congestion compared to placebo. The antihistamine, chlorpheniramine, has a long-established role in addressing allergic symptoms that may accompany upper respiratory infections, including sneezing, runny nose, and itchiness.


Analgesic and Antipyretic Support

The inclusion of acetaminophen (paracetamol) is supported by evidence demonstrating its established effectiveness in reducing fever and alleviating pain associated with respiratory illness, such as headaches and generalized body aches. This component acts as a non-opioid pain reliever and fever reducer, which may complement the decongestant and antihistamine actions of the other ingredients.


Pharmacokinetic Profile

Studies on the absorption and elimination of the three drugs suggest that the fixed-dose formulation is designed to offer sustained relief. Acetaminophen typically reaches peak plasma concentrations rapidly. Pseudoephedrine and chlorpheniramine are also absorbed relatively quickly, with half-lives that may support controlling symptoms over several hours. This pharmacokinetic profile is a key consideration for its use in symptomatic management.

Frequently Asked Questions (FAQ)

Common questions about Sinumed (FAQ)


Q: How quickly can a person generally expect to feel the effects of Sinumed?

Official research indicates that the onset of action for pseudoephedrine, one of the components of this medicine, typically occurs around 30 minutes after taking the dose. This time frame can vary among individuals, but it reflects the general finding established in clinical data.

Q: Does Sinumed start working right away, or does it take a few days?

Official information suggests that the effects can begin within about 30 minutes, not days. However, the label documentation notes that if symptoms like fever last more than three days, or congestion lasts more than seven days, the patient is directed to seek attention from a health professional. This is the official guidance for review.

Q: Is it common to feel tired or dizzy after taking Sinumed?

Official safety documents list dizziness and drowsiness as common adverse effects associated with this medicine. These are considered central nervous system effects. Official safety documentation notes that awareness of these potential effects is part of the product's safety information.

Q: Are there any specific vitamins or supplements that might interact with Sinumed?

Regulatory safety documentation indicates that there is insufficient established information regarding the safety of combining complementary medicines, herbal remedies, and nutritional supplements with the active ingredients in Sinumed. This area is not fully covered in official drug labeling.

Q: Is it okay to drink coffee or caffeine while taking Sinumed?

Regulatory interaction data indicates that combining caffeine with pseudoephedrine, an active component, is a combination that regulatory interaction data notes may require caution. This combination may moderately enhance stimulant effects, such as increased heart rate and blood pressure.

Q: Does Sinumed affect the ability to drive or operate machinery?

Official labeling advises that the medicine may cause dizziness or drowsiness due to its effects on the central nervous system. The labeling specifies that driving or operating machinery is restricted until the user is aware of how the medicine affects them.

Q: Is Sinumed a controlled substance or habit-forming?

The active ingredient pseudoephedrine is generally classified as an Over-The-Counter (OTC) drug, but is subject to regulations as a chemical precursor by the DEA. Official product information does not classify the medicine itself as a controlled substance with potential for habit formation.

Q: Is there a generic version of Sinumed available?

According to regulatory databases and the drug's classification, the medicine often falls under an Abbreviated New Drug Application (ANDA). This regulatory status confirms that generic versions of the product are available on the market.

Q: I missed a dose of Sinumed. What is the general advice for what to do next?

Official patient guidelines describe the protocol for a missed dose, which involves taking the dose if remembered soon after the scheduled time, but skipping it if it is nearly time for the next dose. The label explicitly states that doses must not be doubled.

Q: How is the dose of Sinumed typically adjusted for different body weights?

Official dosing schedules are determined by the patient's age (e.g., pediatric or adult) and the specific drug formulation (e.g., immediate-release or extended-release). Regulatory documents do not specify dose adjustment based on body weight for this medicine.

Q: Can patients with liver conditions use Sinumed?

If the medicine contains acetaminophen, regulatory warnings state that it is strictly contraindicated in patients with severe hepatic impairment or severe active liver disease. Official guidance documents indicate that use with other liver conditions is subject to caution.

Q: Do I need a special monitoring or blood tests while taking Sinumed?

Regulatory documents state that clinical monitoring of liver function is noted for patients with pre-existing liver conditions. Furthermore, monitoring or dose adjustment may be required when the medicine is used in combination with certain interacting drugs.

Q: Why is Sinumed only available by prescription?

The medicine is generally classified under a Human Over-The-Counter (OTC) Drug Labeling. However, the active ingredient pseudoephedrine is subject to state and federal restrictions on its sale due to its status as a chemical precursor.

Q: Is Sinumed meant to cure a condition or just manage the symptoms?

The regulatory indication for the medicine is explicitly for the temporary relief of symptoms associated with the common cold and upper respiratory conditions. The official documentation indicates that the product is intended for symptomatic management, not a cure.

Q: What happens if Sinumed is taken in combination with alcohol?

Official product documentation states that alcohol consumption must be avoided while taking this medicine. Alcohol consumption may increase the risk of liver damage (if the product contains acetaminophen) and can increase central nervous system side effects such as drowsiness or dizziness.

Q: How long does a dose of Sinumed typically stay active in the body?

Regulatory pharmacokinetic data cites the elimination half-life of pseudoephedrine, a key component, as approximately 5.4 hours. The half-life is a scientific estimate of the time required for the amount of drug in the body to reduce by half.

Q: Are the side effects of Sinumed usually mild or more serious?

Official safety data classify adverse events by frequency, ranging from common, typically mild effects (such as nervousness and dry mouth) to rare, serious adverse events (such as Hypertensive Crisis or stroke). Regulatory warnings focus on the management of these potential serious, rare risks.

Q: I've heard Sinumed can cause 'XYZ' side effect. How often does this really happen?

Regulatory documents categorize adverse reactions into frequency groups, such as Common Reactions or Uncommon Reactions. These classifications reflect the likelihood that the effect was observed during clinical trials or noted during post-marketing surveillance.

Q: Can Sinumed cause any unexpected changes in mood?

Official safety documents list central nervous system effects, including nervousness and anxiety, as common or uncommon adverse reactions. Confusion has also been noted in official reports for certain populations, such as older adults.

Q: Can I take Sinumed if I am already taking an over-the-counter pain reliever?

Official regulatory warnings caution against combining the medicine with other products containing its active ingredients. Specifically, this includes other decongestants, other NSAIDs, or any other medicine containing acetaminophen to prevent the risk of overdose and toxicity.

Q: Where can I find the official summary of the research evidence for Sinumed?

The official summary of research evidence, prescribing information, and safety data is publicly available through regulatory sources. This information can typically be found in documents such as the FDA Prescribing Information, often accessed through DailyMed or the National Institutes of Health (NIH).

Q: What should I know about the safety profile of Sinumed?

The official safety profile, as defined in regulatory documents, outlines the major risks associated with the medicine. These include the potential for serious cardiovascular events, the risk of liver damage (if the product contains acetaminophen), and central nervous system side effects.

Q: Does Sinumed contain any ingredients that could cause an allergic reaction?

Regulatory labeling advises that both serious skin reactions and allergic reactions are potential risks of this medication. Official labeling directs the user to review the full list of ingredients, including both active and inactive components (excipients), to identify potential allergens.

Q: What kind of warnings are included on the official Sinumed label?

Official warnings on the label include the risk of severe skin reactions, the potential for dangerously high blood pressure (known as Hypertensive Crisis), and the risk of liver toxicity (if the product contains acetaminophen). A mandatory warning also prohibits use with Monoamine Oxidase Inhibitors (MAOIs).

Q: What does the term 'contraindication' mean in the context of Sinumed?

In the context of regulatory medicine, a contraindication is a condition or situation in which the medicine must not be used. This prohibition is established because the risk of potential harm to the patient substantially outweighs any possible benefit of the drug.

Q: Does Sinumed have any known long-term effects on organ health?

Official regulatory documents indicate that the drug is intended only for short-term use, typically not exceeding seven days. Furthermore, warnings note that the risk of serious cardiovascular events is increased in people who use the medicine for an extended period.

Q: Is there research evidence showing that Sinumed is better than placebo for its main use?

Clinical trials cited in regulatory documents indicate that the pseudoephedrine component of the drug provides a measurable reduction in nasal congestion when compared to a placebo. This research supports the decongestant action of the medicine.

How should Sinumed be stored and disposed of?

How to Store and Dispose of Sinumed

Sinumed (Pseudoephedrine Hydrochloride) must be stored strictly according to the conditions defined in the official regulatory labeling to ensure product stability and safety.

Storage Requirements

The medicine should be stored at controlled room temperature, generally maintained between 20°C and 25°C (68°F and 77°F). It must be protected from excessive heat, moisture, and light. The tablets must remain in the original container, which should be kept tightly closed to maintain integrity. As a critical safety requirement, Sinumed must be stored out of the reach of children.

Disposal Instructions

Expired or unused Sinumed must be disposed of in compliance with local regulations. The preferred method is through an authorized drug take-back program. If a take-back program is unavailable, the product should be mixed with an undesirable substance (such as used coffee grounds or cat litter) in a sealed bag or container and discarded in the household trash. The medicine must not be flushed down the toilet or poured down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Sinumed found in:

A-Z Index: